Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy

Objective: To assess the effect of intrathecal baclofen on spastic dysarthia in cerebral palsy. Design: Single case study. Methods: Functional outcome measures, including the Assessment of Intelligibility of Dysarthric Speech, were performed before and after a trial of intrathecal baclofen in an adu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical rehabilitation 2006-03, Vol.20 (3), p.228-231
Hauptverfasser: Leary, S M, Gilpin, P, Lockley, L, Rodriguez, L, Jarrett, L, Stevenson, V L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 231
container_issue 3
container_start_page 228
container_title Clinical rehabilitation
container_volume 20
creator Leary, S M
Gilpin, P
Lockley, L
Rodriguez, L
Jarrett, L
Stevenson, V L
description Objective: To assess the effect of intrathecal baclofen on spastic dysarthia in cerebral palsy. Design: Single case study. Methods: Functional outcome measures, including the Assessment of Intelligibility of Dysarthric Speech, were performed before and after a trial of intrathecal baclofen in an adult patient with spastic dysarthria due to cerebral palsy. The patient proceeded to intrathecal baclofen pump implantation and was reassessed after six months of continuous intrathecal baclofen therapy. Results: Improvement in function including speech intelligibility was seen following the intrathecal baclofen trial. The improvement was sustained at six months post pump implantation. Conclusions: Intrathecal baclofen improved functional intelligibility of speech in a carefully selected subject. The Assessment of Intelligibility of Dysarthric Speech was found to be a useful quantitative tool to assess the effect of intrathecal baclofen on spastic dysarthria.
doi_str_mv 10.1191/0269215506cr940oa
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67896077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1191_0269215506cr940oa</sage_id><sourcerecordid>67896077</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-28686e61da0ccbf342c261f17e30f6510e392204fb75407c5cd6e0fb9a421a6a3</originalsourceid><addsrcrecordid>eNqFkU1LxDAQhoMouq7-AC9SPHjrOpOmSXsU8QsEL3oTSpqdaKTb1qQV-u_NsguCIp6GYZ555-Nl7ARhgVjiBXBZcsxzkMaXAjq9w2YolEqhUNkum63r6Ro4YIchvANAwQXuswOUMhOZwBl7uW8Hr4c3MrpJam2azlKbxNzrfkrcqvfdJ4XEjq0ZXNdGyLUDNY17dbVr3DAlnU1CT2TeYiUx5Kn2kep1E6YjtmdjpONtnLPnm-unq7v04fH2_uryITVC8iHlhSwkSVxqMKa2meCGS7SoKAMrcwTKSs5B2FrlApTJzVIS2LrUgqOWOpuz841u3PZjpDBUKxdM3FK31I2hkqooJSj1L5grFJBLjODZD_C9G308P1QcQPH47TJCuIGM70LwZKveu5X2U4VQrQ2qfhkUe063wmO9ouV3x9aRCCw2QNCv9D31b8Uvi2CalQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200729409</pqid></control><display><type>article</type><title>Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy</title><source>MEDLINE</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>SAGE Complete A-Z List</source><creator>Leary, S M ; Gilpin, P ; Lockley, L ; Rodriguez, L ; Jarrett, L ; Stevenson, V L</creator><creatorcontrib>Leary, S M ; Gilpin, P ; Lockley, L ; Rodriguez, L ; Jarrett, L ; Stevenson, V L</creatorcontrib><description>Objective: To assess the effect of intrathecal baclofen on spastic dysarthia in cerebral palsy. Design: Single case study. Methods: Functional outcome measures, including the Assessment of Intelligibility of Dysarthric Speech, were performed before and after a trial of intrathecal baclofen in an adult patient with spastic dysarthria due to cerebral palsy. The patient proceeded to intrathecal baclofen pump implantation and was reassessed after six months of continuous intrathecal baclofen therapy. Results: Improvement in function including speech intelligibility was seen following the intrathecal baclofen trial. The improvement was sustained at six months post pump implantation. Conclusions: Intrathecal baclofen improved functional intelligibility of speech in a carefully selected subject. The Assessment of Intelligibility of Dysarthric Speech was found to be a useful quantitative tool to assess the effect of intrathecal baclofen on spastic dysarthria.</description><identifier>ISSN: 0269-2155</identifier><identifier>EISSN: 1477-0873</identifier><identifier>DOI: 10.1191/0269215506cr940oa</identifier><identifier>PMID: 16634341</identifier><identifier>CODEN: CEHAEN</identifier><language>eng</language><publisher>Thousand Oaks, CA: Sage Publications</publisher><subject>Adult ; Baclofen - therapeutic use ; Cerebral palsy ; Cerebral Palsy - complications ; Cerebral Palsy - rehabilitation ; Drugs ; Dysarthria ; Dysarthria - etiology ; Dysarthria - rehabilitation ; GABA Agonists - therapeutic use ; Humans ; Infusion Pumps, Implantable ; Injections, Spinal ; Male ; Treatment methods</subject><ispartof>Clinical rehabilitation, 2006-03, Vol.20 (3), p.228-231</ispartof><rights>2006 Arnold</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-28686e61da0ccbf342c261f17e30f6510e392204fb75407c5cd6e0fb9a421a6a3</citedby><cites>FETCH-LOGICAL-c462t-28686e61da0ccbf342c261f17e30f6510e392204fb75407c5cd6e0fb9a421a6a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1191/0269215506cr940oa$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1191/0269215506cr940oa$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,12844,21817,27922,27923,30997,30998,43619,43620</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16634341$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leary, S M</creatorcontrib><creatorcontrib>Gilpin, P</creatorcontrib><creatorcontrib>Lockley, L</creatorcontrib><creatorcontrib>Rodriguez, L</creatorcontrib><creatorcontrib>Jarrett, L</creatorcontrib><creatorcontrib>Stevenson, V L</creatorcontrib><title>Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy</title><title>Clinical rehabilitation</title><addtitle>Clin Rehabil</addtitle><description>Objective: To assess the effect of intrathecal baclofen on spastic dysarthia in cerebral palsy. Design: Single case study. Methods: Functional outcome measures, including the Assessment of Intelligibility of Dysarthric Speech, were performed before and after a trial of intrathecal baclofen in an adult patient with spastic dysarthria due to cerebral palsy. The patient proceeded to intrathecal baclofen pump implantation and was reassessed after six months of continuous intrathecal baclofen therapy. Results: Improvement in function including speech intelligibility was seen following the intrathecal baclofen trial. The improvement was sustained at six months post pump implantation. Conclusions: Intrathecal baclofen improved functional intelligibility of speech in a carefully selected subject. The Assessment of Intelligibility of Dysarthric Speech was found to be a useful quantitative tool to assess the effect of intrathecal baclofen on spastic dysarthria.</description><subject>Adult</subject><subject>Baclofen - therapeutic use</subject><subject>Cerebral palsy</subject><subject>Cerebral Palsy - complications</subject><subject>Cerebral Palsy - rehabilitation</subject><subject>Drugs</subject><subject>Dysarthria</subject><subject>Dysarthria - etiology</subject><subject>Dysarthria - rehabilitation</subject><subject>GABA Agonists - therapeutic use</subject><subject>Humans</subject><subject>Infusion Pumps, Implantable</subject><subject>Injections, Spinal</subject><subject>Male</subject><subject>Treatment methods</subject><issn>0269-2155</issn><issn>1477-0873</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkU1LxDAQhoMouq7-AC9SPHjrOpOmSXsU8QsEL3oTSpqdaKTb1qQV-u_NsguCIp6GYZ555-Nl7ARhgVjiBXBZcsxzkMaXAjq9w2YolEqhUNkum63r6Ro4YIchvANAwQXuswOUMhOZwBl7uW8Hr4c3MrpJam2azlKbxNzrfkrcqvfdJ4XEjq0ZXNdGyLUDNY17dbVr3DAlnU1CT2TeYiUx5Kn2kep1E6YjtmdjpONtnLPnm-unq7v04fH2_uryITVC8iHlhSwkSVxqMKa2meCGS7SoKAMrcwTKSs5B2FrlApTJzVIS2LrUgqOWOpuz841u3PZjpDBUKxdM3FK31I2hkqooJSj1L5grFJBLjODZD_C9G308P1QcQPH47TJCuIGM70LwZKveu5X2U4VQrQ2qfhkUe063wmO9ouV3x9aRCCw2QNCv9D31b8Uvi2CalQ</recordid><startdate>200603</startdate><enddate>200603</enddate><creator>Leary, S M</creator><creator>Gilpin, P</creator><creator>Lockley, L</creator><creator>Rodriguez, L</creator><creator>Jarrett, L</creator><creator>Stevenson, V L</creator><general>Sage Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88J</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>200603</creationdate><title>Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy</title><author>Leary, S M ; Gilpin, P ; Lockley, L ; Rodriguez, L ; Jarrett, L ; Stevenson, V L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-28686e61da0ccbf342c261f17e30f6510e392204fb75407c5cd6e0fb9a421a6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Baclofen - therapeutic use</topic><topic>Cerebral palsy</topic><topic>Cerebral Palsy - complications</topic><topic>Cerebral Palsy - rehabilitation</topic><topic>Drugs</topic><topic>Dysarthria</topic><topic>Dysarthria - etiology</topic><topic>Dysarthria - rehabilitation</topic><topic>GABA Agonists - therapeutic use</topic><topic>Humans</topic><topic>Infusion Pumps, Implantable</topic><topic>Injections, Spinal</topic><topic>Male</topic><topic>Treatment methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leary, S M</creatorcontrib><creatorcontrib>Gilpin, P</creatorcontrib><creatorcontrib>Lockley, L</creatorcontrib><creatorcontrib>Rodriguez, L</creatorcontrib><creatorcontrib>Jarrett, L</creatorcontrib><creatorcontrib>Stevenson, V L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical rehabilitation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leary, S M</au><au>Gilpin, P</au><au>Lockley, L</au><au>Rodriguez, L</au><au>Jarrett, L</au><au>Stevenson, V L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy</atitle><jtitle>Clinical rehabilitation</jtitle><addtitle>Clin Rehabil</addtitle><date>2006-03</date><risdate>2006</risdate><volume>20</volume><issue>3</issue><spage>228</spage><epage>231</epage><pages>228-231</pages><issn>0269-2155</issn><eissn>1477-0873</eissn><coden>CEHAEN</coden><abstract>Objective: To assess the effect of intrathecal baclofen on spastic dysarthia in cerebral palsy. Design: Single case study. Methods: Functional outcome measures, including the Assessment of Intelligibility of Dysarthric Speech, were performed before and after a trial of intrathecal baclofen in an adult patient with spastic dysarthria due to cerebral palsy. The patient proceeded to intrathecal baclofen pump implantation and was reassessed after six months of continuous intrathecal baclofen therapy. Results: Improvement in function including speech intelligibility was seen following the intrathecal baclofen trial. The improvement was sustained at six months post pump implantation. Conclusions: Intrathecal baclofen improved functional intelligibility of speech in a carefully selected subject. The Assessment of Intelligibility of Dysarthric Speech was found to be a useful quantitative tool to assess the effect of intrathecal baclofen on spastic dysarthria.</abstract><cop>Thousand Oaks, CA</cop><pub>Sage Publications</pub><pmid>16634341</pmid><doi>10.1191/0269215506cr940oa</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0269-2155
ispartof Clinical rehabilitation, 2006-03, Vol.20 (3), p.228-231
issn 0269-2155
1477-0873
language eng
recordid cdi_proquest_miscellaneous_67896077
source MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); SAGE Complete A-Z List
subjects Adult
Baclofen - therapeutic use
Cerebral palsy
Cerebral Palsy - complications
Cerebral Palsy - rehabilitation
Drugs
Dysarthria
Dysarthria - etiology
Dysarthria - rehabilitation
GABA Agonists - therapeutic use
Humans
Infusion Pumps, Implantable
Injections, Spinal
Male
Treatment methods
title Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T07%3A46%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intrathecal%20baclofen%20therapy%20improves%20functional%20intelligibility%20of%20speech%20in%20cerebral%20palsy&rft.jtitle=Clinical%20rehabilitation&rft.au=Leary,%20S%20M&rft.date=2006-03&rft.volume=20&rft.issue=3&rft.spage=228&rft.epage=231&rft.pages=228-231&rft.issn=0269-2155&rft.eissn=1477-0873&rft.coden=CEHAEN&rft_id=info:doi/10.1191/0269215506cr940oa&rft_dat=%3Cproquest_cross%3E67896077%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200729409&rft_id=info:pmid/16634341&rft_sage_id=10.1191_0269215506cr940oa&rfr_iscdi=true